Carri Boiselle

Carri Boiselle has a diverse work experience spanning over 20 years. Carri is currently working at Intellia Therapeutics, Inc. as a Principal Scientist since January 2021. Prior to this role, they served as a Senior Scientist from February 2019 to January 2021 and as a Scientist from June 2016 to February 2019.

Before joining Intellia Therapeutics, Inc., Carri worked at Biogen as a Senior Associate Scientist from July 2015 to May 2016.

From 2008 to 2015, Carri was associated with Novartis Institutes for BioMedical Research (NIBR). During this time, they worked as a Scientist I from August 2012 to June 2015. Carri also held the position of Green Team Co-Chair and Co-Creator from February 2009 to January 2015. Additionally, they worked as a Scientific Associate II during an unspecified period within this timeframe.

Prior to Novartis, Carri worked at Ore Pharmaceuticals (formerly known as Gene Logic) as a Senior Research Associate from January 2006 to August 2008.

Their earlier experience includes working at Neurogen Corporation as a Research Associate I-II from June 2003 to January 2006, and at Pfizer as a College Summer Intern from May 2000 to August 2002.

Carri Boiselle completed a Bachelor of Science (BS) degree in Ecology and Evolutionary Biology at the University of Connecticut from 1999 to 2003. Later, from 2008 to 2013, they pursued a Master's degree in Environmental Management and Sustainability at Harvard University.